Abstract

BackgroundDue to the important role of rifamycin in curing tuberculosis infection, the study on rifamycin has never been stopped. Although RifZ, which locates within the rifamycin biosynthetic cluster, has recently been characterized as a pathway-specific regulator for rifamycin biosynthesis, little is known about the regulation of rifamycin export.ResultsIn this work, we proved that the expression of the rifamycin efflux pump (RifP) was regulated by RifQ, a TetR-family transcriptional regulator. Deletion of rifQ had little impact on bacterial growth, but resulted in improved rifamycin production, which was consistent with the reverse transcription PCR results that RifQ negatively regulated rifP’s transcription. With electrophoretic mobility shift assay and DNase I Footprinting assay, RifQ was found to directly bind to the promoter region of rifP, and a typical inverted repeat was identified within the RifQ-protected sequences. The transcription initiation site of rifP was further characterized and found to be upstream of the RifQ binding sites, well explaining the RifQ-mediated repression of rifP’s transcription in vivo. Moreover, rifamycin B (the end product of rifamycin biosynthesis) remarkably decreased the DNA binding affinity of RifQ, which led to derepression of rifamycin export, reducing the intracellular concentration of rifamycin B as well as its toxicity against the host.ConclusionsHere, we proved that the export of rifamycin B was repressed by RifQ in Amycolatopsis mediterranei, and the RifQ-mediated repression could be specifically relieved by rifamycin B, the end product of rifamycin biosynthesis, based on which a feedback model was proposed for regulation of rifamycin export. With the findings here, one could improve the antibiotic yield by simply inactivating the negative regulator of the antibiotic transporter.

Highlights

  • Due to the important role of rifamycin in curing tuberculosis infection, the study on rifamycin has never been stopped

  • Compared with the wild type, ΔrifQ showed no significant difference in growth rate (Fig. 1a), but produced more than twofold rifamycin B (Fig. 1b)

  • We noticed the rifamycin production was partially restored in rifQ+, and this incomplete complementation of the phenotype was probably caused by the unstable expression of rifQ, which was cloned on an episomal plasmid pDXM4

Read more

Summary

Introduction

Due to the important role of rifamycin in curing tuberculosis infection, the study on rifamycin has never been stopped. RifZ, which locates within the rifamycin biosynthetic cluster, has recently been characterized as a pathway-specific regulator for rifamycin biosynthesis, little is known about the regulation of rifamycin export. To facilitate the study of the rifamycin biosynthesis, the nearly 100-kb rifamycin biosynthetic cluster (rif) was first sequenced in A. mediterranei S699 [13]. RifZ, one of the two regulators within rif cluster, was found to be involved in rifamycin biosynthesis and was characterized as a pathway-specific regulator for rif transcription [16]. It is still unclear whether the export of rifamycin is regulated. The biological function of RifQ, the other regulator annotated within rif cluster, is unknown

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call